DecImmune Therapeutics Secures $2.25 Million in Development Funding

News   Feb 27, 2013

 
DecImmune Therapeutics Secures $2.25 Million in Development Funding
 
 
 

RELATED ARTICLES

CMC Biologics Announces Development and Manufacturing Agreement with Harpoon Therapeutics

News

Companies have entered into agreement for the development and manufacturing of three TriTAC molecules for the treatment of cancers.

READ MORE

Some Immune Cells May Help Tumors Instead of Destroying Them

News

New data shows that neutrophils promote tumor progression and can actually hamper the work of immunotherapy in lung cancer.

READ MORE

IDEX Health & Science Announces Acquisition of New Microfluidics Company

News

IDEX Health & Science, LLC announced the acquisition of thinXXS Microtechnology that will accelerate growth of its microfluidics consumables business.

READ MORE

 

Comments | 0 ADD COMMENT

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE